The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 Update

23 Mar 2020 12:00

RNS Number : 2040H
Location Sciences Group PLC
23 March 2020
 

23 March 2020

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Covid-19 Update

 

Given the current and rapidly changing developments regarding COVID-19, Location Sciences (AIM: LSAI) provides the following update.

Ways of working

We are a virtual business, operating across four locations globally. All of our systems are in the cloud, with our normal day involving Slack stand ups and Zoom conference calls. We have all been able to adjust to working from home very easily.

Business impact

We are still very small and a large part of our revenues are repeatable licence deals. We are also heavily H2, and specifically Q4, weighted in our forecasts and business plans to take into account seasonal spikes in advertising. The market has, of course, shifted and we are living in uncertain times. In addition, as we work with location advertisers, there will be campaigns that are postponed to later dates. However, we are already seeing new campaigns being launched - for example by companies operating in the pharmaceutical sector. We continue to support our global clients and are continuing to sign new customers up.

R&D

We are an early stage business still in the research and development stage of our product. In many ways, this time allows us to invest in the important engineering work we are undertaking. We are launching an updated version of our platform at the end of April 2020. This will give our customers a clearer picture of how to obtain better value from their location spend and how to drive better performance. This will be needed in the months ahead, as companies look for a competitive edge.

Data for good

As a location data business, with billions of location events, we are exploring how we can use this data (and our data science skills) for good, or wider initiatives we would like to help wherever we can.

EGM Attendance

If you wish to attend the Company's General Meeting convened for 11.00 am on 26 March 2020 via webinar, please register in advance by following this link: https://locationsciences.zoom.us/webinar/register/WN_vNzqXAu9TZmALuHZfvwo4g. After registering, you will receive a confirmation email containing instructions on how to join.

Shareholders will not be able to vote via the webinar, so all shareholders wishing to attend on this basis must vote prior to the General Meeting by submitting a proxy vote by no later than 11.00 a.m. on 24 March 2020. Details of how to appoint a proxy are set out in the Company's circular to shareholders published on 9 March 2020 ("Circular") and available from the Company's website at https://www.locationsciencesgroup.ai/wp-content/uploads/2020/03/March-2020-Circular-and-Notice-of-General-Meeting.pdf

The General Meeting is being held to approve, amongst other things, the Resolutions related to the Company's Placing announced on 6 March 2020.

Mark Slade, Chief Executive Officer, commented "I understand that in these challenging times, communication is paramount. With that in mind, I wanted to share this update on our business operations and reassure our shareholders that their business remains on track to deliver value in 2020".

Terms used in this announcement but not otherwise defined have the meanings given to them in the Circular.

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Shore Capital (Nomad and Joint Broker)

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKNBPDBKDANB
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.